Speaker, I move to suspend the rules and pass the bill (H.R. 3034) to amend the Public Health Service Act to reauthorize the National Bone Marrow Donor Registry, and for other purposes, as amended.  The Clerk read as follows:                               H.R. 3034       Be it enacted by the Senate and House of Representatives of      the United States of America in Congress assembled,     SECTION 1. SHORT TITLE.       This Act may be cited as the ``National Bone Marrow Donor      Registry Reauthorization Act''.     SEC. 2. NATIONAL BONE MARROW DONOR REGISTRY.       (a) National Registry.--Section 379 of the Public Health      Service Act (42 U.S.C. 274k) is amended--       (1) in subsection (a)--       (A) in paragraph (1), by striking ``except that'' and all      that follows and inserting ``except that--       ``(A) such limitations shall not apply to the Chair of the      board (or the Chair-elect) or to the member of the board who      most recently served as the Chair; and       ``(B) 1 additional consecutive 2-year term may be served by      any member of the board who has no employment, governance, or      financial affiliation with any donor center, recruitment      group, transplant center, or cord blood bank.''; and       (B) in paragraph (4)--       (i) by striking ``the Naval Medical Research and      Development Command'' and inserting ``the Department of      Defense Marrow Donor Recruitment and Research Program      operated by the Department of the Navy''; and       (ii) by striking ``Organ'' after ``Division of'';       (2) in subsection (b)--       (A) in paragraph (4), by inserting ``at least'' before      ``annually'';       (B) in paragraph (7), by striking ``and comparisons of      transplant centers regarding search and other costs that      prior to transplantation are charged to patients by      transplant centers; and'';       (C) in paragraph (8), by inserting ``and outreach'' after      ``and demonstration'';       (D) at the end of paragraph (8), by striking the period and      inserting a semicolon;       (E) by redesignating paragraphs (3) through (8) as      paragraphs (4) through (9);       (F) by inserting after paragraph (2), the following:       ``(3) maintain and expand medical emergency contingency      response capabilities in concert with Federal programs for      response to threats of use of terrorist or military weapons      that can damage marrow, such as ionizing radiation or      chemical agents containing mustard, so that the capability of      supporting patients with marrow damage from disease can be      used to support casualties with marrow damage;''; and       (G) by adding at the end the following:       ``(10) conduct and support research to improve the      availability, efficiency, safety, and cost of transplants      from unrelated donors and the effectiveness of Registry      operations;       ``(11) increase the number of umbilical cord blood units      listed in the Registry and assist cord blood banks in the      Registry program in accordance with subsection (c); and       ``(12) establish bylaws and procedures--       ``(A) to prohibit any member of the board of directors of      the Registry who has an employment, governance, or financial      affiliation with a donor center, recruitment group,      transplant center, or cord blood bank from participating in      any decision that materially affects the center, recruitment      group, transplant center, or cord blood bank; and       ``(B) to limit the number of members of the board with any      such affiliation.'';       (3) in subsection (c)--       (A) in clause (ii) of paragraph (2)(A), by striking ``,      including providing updates''; and       (B) in paragraph (3), by striking ``the availability, as a      potential treatment option, of receiving a transplant of bone      marrow from an unrelated donor'' and inserting ``transplants      from unrelated donors as a treatment option and resources for      identifying and evaluating other therapeutic alternatives'';       (4) in subsection (d)--       (A) in paragraph (2)(C), by inserting ``and assist with      information regarding third party payor matters'' after      ``ongoing search for a donor'';       (B) in paragraph (2)(F)--       (i) by redesignating clause (v) as clause (vi); and       (ii) by inserting after clause (iv) the following:       ``(v) Information concerning issues that patients may face      after a transplant regarding continuity of care and quality      of life.''; and       (C) in paragraph (3)(B), by striking ``Office may'' and      inserting ``Office shall'';       (5) in subsection (g), by striking ``the bone marrow donor      program of the Department of the Navy'' and inserting ``the      Department of Defense Marrow Donor Recruitment and Research      Program operated by the Department of the Navy'';       (6) in subsection (h)--       (A) by striking ``Application.--'' and inserting      ``Contracts.--'';       (B) by striking ``To be eligible'' and inserting the      following:       ``(1) Application.--To be eligible''; and       (C) by adding at the end the following:       ``(2) Considerations.--In awarding contracts under this      section, the Secretary shall give substantial weight to the      continued safety of donors and patients and other factors      deemed appropriate by the Secretary.'';       (7) in subsection (i), by striking ``include'' and      inserting ``be''; and       (8) by striking subsection (l).       (b) Bone Marrow Scientific Registry.--Section 379A of the      Public Health Service Act (42 U.S.C. 274l) is amended--       (1) in subsection (a), by adding at the end the following:      ``The scientific registry shall participate in medical      research that has the potential to improve transplant      outcomes.'';       (2) in subsection (c), by striking ``Each such report shall      in addition include the data required in section 379(l)      (relating to pretransplant costs).''; and       (3) by adding after subsection (c) the following:       ``(d) Publicly Available Data.--The scientific registry      shall make relevant scientific information not containing      individually identifiable information available to the public      in the form of summaries and data sets to encourage medical      research and to provide information to transplant programs,      physicians, and patients.''.       (c) Bone Marrow and Marrow Defined.--Part I of title III of      the Public Health Service Act (42 U.S.C. 274k et seq.) is      amended--       (1) by redesignating section 379B as section 379C; and       (2) by inserting after section 379A the following:     ``SEC. 379B. BONE MARROW AND MARROW DEFINED.       ``For purposes of this part, the terms `bone marrow' and      `marrow' include bone marrow and any other source of      hematopoietic progenitor cells the acquisition or use of      which is not inconsistent with Federal law.''.       (d) Authorization of Appropriations.--Section 379C of the      Public Health Service Act, as redesignated by subsection (c),      is amended to read as follows:     ``SEC. 379C. AUTHORIZATION OF APPROPRIATIONS.       ``(a) In General.--For the purpose of carrying out this      part, there are authorized to be appropriated $32,000,000 for      fiscal year 2004, and such sums as may be necessary for each      of the fiscal years 2005 through 2008.       ``(b) Emergency Contingency Response Capabilities.--In      addition to the amounts authorized to be appropriated under      subsection (a), there are authorized to be appropriated such      sums as may be necessary for the maintenance and expansion of      emergency contingency response capabilities under section      379(b)(3).''.  